Posted By Paul Tate, January 30, 2013 at 9:19 AM, in Category: Sustainability
In an effort to slash the amount of potentially harmful waste in the development and production of new drugs and medicines, a group of leading global pharmaceuticals companies have joined forces to help create a new mobile app that guides developers in the use of more environmentally-friendly solvents – a key ingredient in the production process.
The mobile guide was developed with the help of the American Chemical Society Green Chemistry Institute's Pharmaceutical Roundtable, a group of 14 pharmaceuticals companies from around the world including Pfizer, Johnson and Johnson, Merck, Eli Lilly, Novartis, GlaxoSmithKline, Amgen, AstaZeneca, Roche, Sanofi, Boehringer-Ingelheim and Bristol-Myers Squibb.
The app currently covers 60 different types of solvents, and includes details on their chemical structure and physical properties, plus safety, health and environmental ratings.
Traditional production processes and techniques, points out the ACS, can generate between 25 to 100 times more waste than the medicines they are creating, much of which is potentially harmful to the environment. The new Green Solvents app is designed to “foster wider use of the environmentally friendly and sustainable principles of green chemistry” in the manufacture of medicines across the global pharma sector.
Written by Paul Tate
Paul Tate is Research Director and Executive Editor with Frost & Sullivan's Manufacturing Leadership Council. He also directs the Manufacturing Leadership Council's Board of Governors, the Council's annual Critical Issues Agenda, and the Manufacturing Leadership Research Panel. Follow us on Twitter: @MfgExecutive